InNexus Biotechnology Inc. announced in a press release that it has received patent grants in Germany, Spain, France, Great Britain and Italy further expanding patent protection of its DXL technology in Europe.
52272
InNexus Biotechnology receives patent grants in Europe
166509
Ineos to expand range of polyolefins for medical devices
59485
Consortium supports next generation drug discovery
80180
Novartis buys rights to new antibiotic
21178
BlueGnome ranked the fastest growing biotechnology company in the UK
173630
Siemens Energy assigned patent
174383
Genomatica achieves two key commercialization milestones
129407
E-Therapeutics granted US patent for key process
22342
Biotechnology industry pushes for fiscal incentives, duty exemption
99572
Agility expands in Europe
110026
Actis Biologics raising USD 500 million for expansion in Malaysia and India
102311
Perkinelmer expands in India
155748
Drug company stands to benefit from legislation
72721
Xilinx assigned patent for digital signal processing engine
87042
Inntel expands business development team
36202
US patent Office confirms Wider Networks patent
132576
Luxottica expands in Mexico